Deborah Watkins Bruner

20.3k total citations · 9 hit papers
296 papers, 10.8k citations indexed

About

Deborah Watkins Bruner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Deborah Watkins Bruner has authored 296 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Oncology, 90 papers in Pulmonary and Respiratory Medicine and 43 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Deborah Watkins Bruner's work include Cancer survivorship and care (61 papers), Prostate Cancer Diagnosis and Treatment (45 papers) and Prostate Cancer Treatment and Research (39 papers). Deborah Watkins Bruner is often cited by papers focused on Cancer survivorship and care (61 papers), Prostate Cancer Diagnosis and Treatment (45 papers) and Prostate Cancer Treatment and Research (39 papers). Deborah Watkins Bruner collaborates with scholars based in United States, Canada and United Kingdom. Deborah Watkins Bruner's co-authors include Benjamin Movsas, André Konski, Bryce B. Reeve, Howard M. Sandler, Charles Scott, Canhua Xiao, John H. Suh, Ethan Basch, Lori M. Minasian and Jeff M. Michalski and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Deborah Watkins Bruner

287 papers receiving 10.5k citations

Hit Papers

Memantine for the prevention of cognitive dysfunction... 2005 2026 2012 2019 2013 2011 2005 2011 2016 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
    2013 616 citations Paul D. Brown, S. Pugh et al. Neuro-Oncology profile →
  2. Palliative Radiotherapy for Bone Metastases: An ASTRO Evidence-Based Guideline
    2011 571 citations Stephen Lutz, Lawrence Berk et al. International Journal of Radiation Oncology*Biology*Physics profile →
  3. Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone Metastases
    2005 528 citations Deborah Watkins Bruner, John H. Suh et al. profile →
  4. Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer
    2011 473 citations Mahul B. Amin, Deborah Watkins Bruner et al. profile →
  5. Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
    2016 415 citations W. Robert Lee, James J. Dignam et al. Journal of Clinical Oncology profile →
  6. Sexual Satisfaction and the Importance of Sexual Health to Quality of Life Throughout the Life Course of U.S. Adults
    2016 309 citations Deborah Watkins Bruner et al. profile →
  7. Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer
    2018 225 citations Jeff M. Michalski, Jennifer Moughan et al. profile →
  8. Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
    2022 139 citations Debra L. Barton, Lynne I. Wagner et al. Journal of Clinical Oncology profile →
  9. Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update
    2024 52 citations Julienne E. Bower, Christina Lacchetti et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Watkins Bruner United States 50 4.3k 4.0k 2.4k 1.5k 1.3k 296 10.8k
Richard Stephens United Kingdom 51 6.9k 1.6× 7.8k 1.9× 2.7k 1.1× 809 0.6× 754 0.6× 208 14.5k
Geertruida H. de Bock Netherlands 65 4.3k 1.0× 5.9k 1.5× 3.4k 1.4× 508 0.3× 981 0.8× 650 18.7k
Anna E. Barón United States 58 3.7k 0.9× 3.6k 0.9× 1.6k 0.7× 273 0.2× 714 0.6× 231 12.8k
Sunita Ghosh Canada 41 1.7k 0.4× 2.3k 0.6× 1.5k 0.6× 475 0.3× 607 0.5× 436 8.8k
John Horton United States 35 5.2k 1.2× 6.9k 1.7× 2.8k 1.1× 230 0.2× 1.5k 1.2× 104 16.7k
Richard M. Hoffman United States 60 4.5k 1.1× 3.4k 0.8× 1.9k 0.8× 256 0.2× 873 0.7× 342 11.9k
Allison M. Deal United States 53 2.2k 0.5× 4.8k 1.2× 1.7k 0.7× 195 0.1× 1.9k 1.5× 403 10.7k
Ann S. Hamilton United States 63 4.3k 1.0× 5.0k 1.3× 2.4k 1.0× 272 0.2× 1.9k 1.5× 316 13.9k
Sam H. Ahmedzai United Kingdom 40 4.6k 1.1× 9.1k 2.3× 3.3k 1.4× 177 0.1× 4.0k 3.1× 150 18.0k
Susan G. Fisher United States 57 1.9k 0.4× 2.8k 0.7× 2.4k 1.0× 107 0.1× 691 0.5× 228 12.8k

Countries citing papers authored by Deborah Watkins Bruner

Since Specialization
Citations

This map shows the geographic impact of Deborah Watkins Bruner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Watkins Bruner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Watkins Bruner more than expected).

Fields of papers citing papers by Deborah Watkins Bruner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Watkins Bruner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Watkins Bruner. The network helps show where Deborah Watkins Bruner may publish in the future.

Co-authorship network of co-authors of Deborah Watkins Bruner

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Watkins Bruner. A scholar is included among the top collaborators of Deborah Watkins Bruner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Watkins Bruner. Deborah Watkins Bruner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bower, Julienne E., Christina Lacchetti, Yesne Alici, et al.. (2024). Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update. Journal of Clinical Oncology. 42(20). 2456–2487. 52 indexed citations breakdown →
2.
Michalski, Jeff M., Jennifer Moughan, James A. Purdy, et al.. (2023). Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). S4–S5. 3 indexed citations
3.
Lee, W. Robert, James J. Dignam, Mahul B. Amin, et al.. (2023). Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with Favorable-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). S3–S4.
4.
Yeager, Katherine A., et al.. (2023). A Qualitative Study of the Pain Experience of Black Individuals With Cancer Taking Long-Acting Opioids. Cancer Nursing. 47(2). E73–E83. 3 indexed citations
5.
Eldridge, Ronald C., Zhaohui Qin, Nabil F. Saba, et al.. (2023). Unsupervised Hierarchical Clustering of Head and Neck Cancer Patients by Pre-Treatment Plasma Metabolomics Creates Prognostic Metabolic Subtypes. Cancers. 15(12). 3184–3184. 2 indexed citations
6.
Zhan, Yan, Sangchoon Jeon, Deborah Watkins Bruner, et al.. (2023). Longitudinal associations among physical activity, inflammatory markers, and quality of life in patients with head and neck cancer. Head & Neck. 45(8). 1952–1966. 2 indexed citations
7.
Qian, David C., Bryan C. Ulrich, Gang Peng, et al.. (2022). Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral Blood. International Journal of Radiation Oncology*Biology*Physics. 115(5). 1217–1228. 1 indexed citations
8.
Wells, Jessica, Lisa Flowers, C. Christina Mehta, et al.. (2022). Follow-Up to High-Resolution Anoscopy After Abnormal Anal Cytology in People Living with HIV. AIDS Patient Care and STDs. 36(7). 263–271. 7 indexed citations
9.
Eldridge, Ronald C., Karan Uppal, D. Neil Hayes, et al.. (2021). Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient Survival. Cancer Epidemiology Biomarkers & Prevention. 30(10). 1858–1866. 5 indexed citations
10.
Xiao, Canhua, Ronald C. Eldridge, Jonathan J. Beitler, et al.. (2020). Association Among Glucocorticoid Receptor Sensitivity, Fatigue, and Inflammation in Patients With Head and Neck Cancer. Psychosomatic Medicine. 82(5). 508–516. 13 indexed citations
11.
Eldridge, Ronald C., Stephanie L. Pugh, Andy Trotti, et al.. (2019). Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study. Head & Neck. 41(11). 3924–3932. 9 indexed citations
12.
Wagner, Lynne I., Stephanie L. Pugh, William Small, et al.. (2016). Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial. Cancer. 123(3). 485–493. 25 indexed citations
13.
Lee, W. Robert, James J. Dignam, Mahul B. Amin, et al.. (2016). Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer. Journal of Clinical Oncology. 34(20). 2325–2332. 415 indexed citations breakdown →
14.
Atherton, Pamela J., Deborah Watkins Bruner, Carolyn Gotay, et al.. (2015). The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591). Journal of Pain and Symptom Management. 50(4). 470–479.e9. 17 indexed citations
15.
Wells, Jessica, Marcia McDonnell Holstad, Tami L. Thomas, & Deborah Watkins Bruner. (2014). An Integrative Review of Guidelines for Anal Cancer Screening in HIV-Infected Persons. AIDS Patient Care and STDs. 28(7). 350–357. 50 indexed citations
16.
Brown, Paul D., S. Pugh, Nadia N. Laack, et al.. (2013). Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-Oncology. 15(10). 1429–1437. 616 indexed citations breakdown →
17.
Lutz, Stephen, Lawrence Berk, Eric Chang, et al.. (2011). Palliative Radiotherapy for Bone Metastases: An ASTRO Evidence-Based Guideline. International Journal of Radiation Oncology*Biology*Physics. 79(4). 965–976. 571 indexed citations breakdown →
18.
Bruner, Deborah Watkins, et al.. (2011). Patterns of missing mini mental status exam (MMSE) in radiation therapy oncology group (RTOG) brain cancer trials. Journal of Neuro-Oncology. 105(2). 383–395. 6 indexed citations
19.
Konski, André, Deborah Watkins Bruner, Alexandra L. Hanlon, et al.. (2004). Intensity modulated radiation therapy (IMRT) is a cost-effective treatment for intermediate risk prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 60(1). S144–S144. 5 indexed citations
20.
Grigsby, Perry W., Anthony H. Russell, Deborah Watkins Bruner, et al.. (1995). Late injury of cancer therapy on the female reproductive tract. International Journal of Radiation Oncology*Biology*Physics. 31(5). 1281–1299. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Stephens Breakdown of academic impact, for papers by Geertruida H. de Bock Breakdown of academic impact, for papers by Anna E. Barón Breakdown of academic impact, for papers by Sunita Ghosh Breakdown of academic impact, for papers by John Horton Breakdown of academic impact, for papers by Richard M. Hoffman Breakdown of academic impact, for papers by Allison M. Deal Breakdown of academic impact, for papers by Ann S. Hamilton Breakdown of academic impact, for papers by Sam H. Ahmedzai Breakdown of academic impact, for papers by Susan G. Fisher
Rankless by CCL
2026